Study of Amcenestrant (SAR439859) Versus Tamoxifen for Patients With Hormone Receptor-positive (HR+) Early Breast Cancer, Who Have Discontinued Adjuvant Aromatase Inhibitor Therapy Due to Treatment-related Toxicity
Clinical trial NCT05128773 · TERMINATED
Trial details
- NCT number
- NCT05128773
- Sponsor
- Sanofi
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-17
- Primary completion
- 2022-10-13
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.